.Attributes Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires incorporation of patients with MASLD and size of liver results in cardio-- kidney-- metabolic trials, when data recommend mechanistically probable perks and also scientific safety-- and also details points to consider for trial design and also regulatory approval.